MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$3,150,228
EPS
-$0.11
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
General & administrative
927,197
755,936.5*
273,853
57,658
Research & development
2,256,162
1,969,662*
677,474
-
Total operating expenses
3,183,359
2,725,598.5
951,327
57,658
Loss from operations
-3,183,359
-2,725,598.5*
-951,327
-57,658
Interest expense
-
-2,234.5*
4,090
3,091
Other income
33,131
19,865.5*
1,358
403
Net loss
-3,150,228
-2,703,498.5
-954,059
-60,346
Basic EPS
-0.11
-0.101
-0.04
0
Diluted EPS
-0.11
-0.101
-0.04
0
Basic Average Shares
28,344,545
26,892,311
25,599,673
24,000,000
Diluted Average Shares
28,344,545
26,892,311
25,599,673
24,000,000
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$3,150,228
Other income
$33,131
Loss from operations
-$3,183,359
Total operating
expenses
$3,183,359
Research & development
$2,256,162
General &
administrative
$927,197
Buy us a coffee
Curanex Pharmaceuticals Inc (CURX)
Curanex Pharmaceuticals Inc (CURX)